Stocks and Investing Stocks and Investing
Mon, September 14, 2009
Fri, September 11, 2009
Thu, September 10, 2009
Wed, September 9, 2009
Tue, September 8, 2009

50.88% Of All NASDAQ Trading Tuesday Was Short Selling. LIOX, MVIS, CPBY, CPTS, GNVC, AMSG Highest % Of Daily Trading Volume S


Published on 2009-09-08 16:45:18, Last Modified on 2010-12-22 14:43:38 - WOPRAI
  Print publication without navigation


September 9, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Tuesday, September 8th, 2009 and come to the following statistical conclusions. There were 6,655 stocks with daily short volume reported and total NASDAQ trading volume of 1,572,916,934 shares. Total Daily Short Volume was 800,306,209 shares. 50.88% of all trading on the NASDAQ Tuesday was short selling. The chart below highlights 6 stocks that had unusually high percentages of their total daily trading volume attributed to short sales. Lionbridge Technologies (NASDAQ: LIOX), Microvision (NASDAQ: MVIS), China Information Security Technology (NASDAQ: CPBY), Conceptus (NASDAQ: CPTS), GenVec (NASDAQ: GNVC) and AmSurg (NASDAQ: AMSG). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

DATE SYMBOL SHORT VOLUME TOTAL VOLUME MARKET PERCENT

20090908 LIOX 94,926 102,853 Q 92.29%

20090908 MVIS 109,956 125,484 Q 87.63%

20090908 CPBY 100,563 121,444 Q 82.81%

20090908 CPTS 81,762 100,345 Q 81.48%

20090908 GNVC 210,398 266,134 Q 79.06%

20090908 AMSG 89,338 117,174 Q 76.24%

In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesai naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales.

Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities.

The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted.

Lionbridge Technologies, Inc. (NASDAQ: LIOX), together with its subsidiaries, provides language, development, and testing services to businesses in the technology, consumer products, life sciences, publishing, financial services, manufacturing, government, automotive, and retail industries. Its services enable its clients to develop, release, manage, and maintain their enterprise content and technology applications; and related technical support, training materials, and sales and marketing information. The companyais solutions include product and content globalization; content and eLearning courseware development; interpretation services; application development and maintenance; software and hardware testing; product certification; and competitive analysis. It also provides interpretation communication services in approximately 360 languages and dialects, including onsite interpretation, over-the-phone interpretation, and interpreter testing, training, and assessment services to government organizations and businesses. In addition, the company develops, re-engineers, and optimizes information technology applications; and performs testing to ensure the quality, interoperability, usability, and performance of clientsai software, consumer technology products, Web sites, search engines, and content. It offers its testing services under the VeriTest brand name. The company has operations in North America, Latin America, Europe, and Asia. It has a partnership with Open Text Corporation to Streamline Regulatory Compliance Solutions for Pharmaceutical Companies. The company was founded in 1996 and is headquartered in Waltham, Massachusetts.

Microvision, Inc. (NASDAQ: MVIS) engages in the development of miniature display and imaging engines based on its integrated photonics module technology platform. Its technology platform combines bi-axial/two dimensional micro-electrical mechanical system light scanning technologies, lasers, optics, and electronics with its system controls to create a video or still image from a small form factor device. The companyais products include Pico projector displays for portable hand-held devices, including mobile phones, as well as accessory devices that connect to a mobile video source, such as a personal media player, cell phone, or laptop computer. Its products also include vehicle/automotive head-up display for driver safety that reduces the distraction of looking away from the road to read information, such as GPS mapping images, audio controls, and other automobile instrumentation. In addition, the companyais products include near-eye wearable display platform to provide personal viewing of information that originates from a mobile device and arrives at the display through a wired or wireless connection. Further, its products include ROV hand held bar code scanners to accommodate mobile workers with the data collection solutions on the mobile platforms of their choosing, as well as bar code scanner enabled enterprise solutions. The company, based on its light scanning technologies, also develops and produces prototype and demonstration units for commercial customers and the United States government. It serves customers in the consumer, automotive, defense, industrial, and medical markets. Microvision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

China Information Security Technology, Inc. (NASDAQ: CPBY), through its subsidiaries, provides integrated solutions for the information security sector, and geographic information systems (GIS) solutions to the public security and civil-use markets in the People's Republic of China. The company specializes in providing information security technology, GIS, and digital hospital information systems; and the sale of computer hardware and software, as well as in the provision of Certificate Authority, an application platform and e-Government solution technology, and multimedia display and control solutions. Its products and services include public security information technology comprising first responder co-ordination platform, a software program which integrates the contact numbers for general police, fire, traffic, and other related government organizations into one contact number, and enables these agencies to consolidate and improve their public emergency response; intelligent border control systems, which store biometric information, such as finger-prints and facial features from passengers in a database, and integrate it with infrared and license plate recognition technologies to enable the automation of border control checkpoints; residence card information management system; and police-use GIS and civil-use GIS platform. The companyais products and services are used for public security, traffic control, fire control, medical rescue, border control, and surveying and mapping. China Information Security Technology, Inc. is headquartered in Shenzhen, the Peopleais Republic of China.

Conceptus, Inc. (NASDAQ: CPTS) designs, develops, and markets minimally invasive devices for reproductive medical applications in the United States. The company offers Essure, a permanent birth control system for women. The Essure system uses a micro-insert that is delivered into a woman's fallopian tubes to provide permanent birth control by causing a benign tissue in-growth that blocks the fallopian tubes. The company distributes its products through direct sales force and distributor networks, as well as media, including television, radio, direct mail, and print to gynecologists and general practitioners. Conceptus, Inc. was founded in 1992 and is headquartered in Mountain View, California.

GenVec, Inc. (NASDAQ: GNVC), a clinical stage biopharmaceutical company, develops gene-based therapeutic drugs and vaccines in the United States. Its lead therapeutic product candidate, TNFerade biologic, is under Phase III trial for first-line treatment of inoperable, locally advanced pancreatic cancer. The company is also evaluating TNFerade biologic, wfor the treatment of various cancers, including esophageal cancer, rectal cancer, and head and neck cancer. In addition, it is developing TherAtoh, a preclinical program involving the delivery of the human atonal gene for the production of therapeutic proteins by cells in the inner ear. Further, GenVec uses its proprietary adenovector technology to develop vaccines for infectious diseases, including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus, and HSV-2. It has strategic alliances and research contracts with the U.S. department of homeland security, the U.S. department of agriculture, PATHaiS malaria vaccine initiative, the U.S. naval medical research center, and the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The company was founded in 1992 and is based in Gaithersburg, Maryland.

AmSurg Corp. (NASDAQ: AMSG), through its wholly owned subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers in partnership with physician practice groups in the United States. The companyais surgery centers perform colonoscopy and other endoscopy procedures in the area of gastroenterology; cataracts and retinal laser surgery in the area of ophthalmology; and knee and shoulder arthroscopy and carpal tunnel repair in the area of orthopedics. As of December 31, 2008, it owned interest in 189 surgery centers in 32 states and the District of Columbia, including 132 centers performed gastrointestinal endoscopy procedures, 36 centers performed ophthalmology surgery procedures, 15 centers were multi-specialty centers, and 6 centers performed orthopaedic procedures. The company markets its surgery centers directly to patients; and referring physicians and third-party payors, including health maintenance organizations, preferred provider organizations, other managed care organizations, and employers. AmSurg Corp. was founded in 1992 and is headquartered in Nashville, Tennessee.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each monthais short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net

Contributing Sources